MA29095B1 - Derives de chromane utiles comme antagonistes de la pompe a acide - Google Patents

Derives de chromane utiles comme antagonistes de la pompe a acide

Info

Publication number
MA29095B1
MA29095B1 MA29996A MA29996A MA29095B1 MA 29095 B1 MA29095 B1 MA 29095B1 MA 29996 A MA29996 A MA 29996A MA 29996 A MA29996 A MA 29996A MA 29095 B1 MA29095 B1 MA 29095B1
Authority
MA
Morocco
Prior art keywords
antagonists
derivatives useful
acid pump
chromane derivatives
chromane
Prior art date
Application number
MA29996A
Other languages
English (en)
French (fr)
Inventor
Madoka Jinno
Hirohisa Shimokawa
Tatsuya Yamagishi
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA29095B1 publication Critical patent/MA29095B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA29996A 2004-12-17 2007-06-15 Derives de chromane utiles comme antagonistes de la pompe a acide MA29095B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63696304P 2004-12-17 2004-12-17
US69577205P 2005-06-29 2005-06-29

Publications (1)

Publication Number Publication Date
MA29095B1 true MA29095B1 (fr) 2007-12-03

Family

ID=35995811

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29996A MA29095B1 (fr) 2004-12-17 2007-06-15 Derives de chromane utiles comme antagonistes de la pompe a acide

Country Status (18)

Country Link
US (1) US20090291977A1 (enExample)
EP (1) EP1838309B1 (enExample)
JP (1) JP2008524199A (enExample)
KR (1) KR20070086294A (enExample)
AP (1) AP2007004023A0 (enExample)
AT (1) ATE405262T1 (enExample)
AU (1) AU2005315303A1 (enExample)
BR (1) BRPI0519598A2 (enExample)
CA (1) CA2591412A1 (enExample)
DE (1) DE602005009257D1 (enExample)
EA (1) EA011512B1 (enExample)
ES (1) ES2313444T3 (enExample)
IL (1) IL183602A0 (enExample)
MA (1) MA29095B1 (enExample)
MX (1) MX2007007010A (enExample)
NO (1) NO20072764L (enExample)
TN (1) TNSN07227A1 (enExample)
WO (1) WO2006064339A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007026218A2 (en) * 2005-09-01 2007-03-08 Pfizer Japan Inc. Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists
KR20080108129A (ko) * 2006-03-17 2008-12-11 라퀄리아 파마 인코포레이티드 크로메인 유도체
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
MX2016006657A (es) 2013-11-22 2016-10-12 CL BioSciences LLC Antagonistas de gastrina (por ejemplo, yf476, netazepido) para el tratamiento y prevencion de osteoporosis.
JP6315708B2 (ja) * 2015-06-22 2018-04-25 日本電信電話株式会社 リチウム空気二次電池、リチウム空気二次電池の製造方法及びリチウム空気二次電池を備えた装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
EA008304B1 (ru) * 2002-11-19 2007-04-27 Алтана Фарма Аг 8-замещённые имидазопиридины

Also Published As

Publication number Publication date
KR20070086294A (ko) 2007-08-27
AU2005315303A1 (en) 2006-06-22
NO20072764L (no) 2007-07-03
IL183602A0 (en) 2007-09-20
CA2591412A1 (en) 2006-06-22
EA200701087A1 (ru) 2008-02-28
ES2313444T3 (es) 2009-03-01
EP1838309B1 (en) 2008-08-20
ATE405262T1 (de) 2008-09-15
JP2008524199A (ja) 2008-07-10
EP1838309A1 (en) 2007-10-03
BRPI0519598A2 (pt) 2009-03-10
TNSN07227A1 (fr) 2008-11-21
EA011512B1 (ru) 2009-04-28
US20090291977A1 (en) 2009-11-26
DE602005009257D1 (de) 2008-10-02
MX2007007010A (es) 2007-07-10
AP2007004023A0 (en) 2007-06-30
WO2006064339A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
EP1976511A4 (en) FLUORATED ARYLAMIDE DERIVATIVES
EP2097111A4 (en) HETERODIMERS OF GLUTAMIC ACID
DK1660431T3 (da) Phenoxyeddikesyrederivater
EP1968937A4 (en) DEAZAPURINANALOGA OF 1-AZA-L-NUCLEOSIDES
CL2013002895A1 (es) Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005).
EP1638626A4 (en) PUMP
DE50212761D1 (de) Neuartige aminodicarbonsäurederivate
FI20055616A0 (fi) Menetelmä valmisteen rakenteen muokkaamiseen
NL1029250A1 (nl) Benzimidazoloncarbonzuurderivaten.
EP1951231A4 (en) CAMPTOTHECIN DERIVATIVES AS CHEMOROSO-SENSITIVE AGENTS
MA29095B1 (fr) Derives de chromane utiles comme antagonistes de la pompe a acide
DE602004014277D1 (de) Neue Dicarbonsäurederivate
DK1636288T3 (da) Tværbindende vandige polyurethandispersioner
FR2880540B1 (fr) Utilisation de derives de la purine comme inhibiteurs de la proteine hsp90
CY2011018I1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
EE00773U1 (et) Meetod vaba estsitalopraam-aluse v?i selle soola tootmiseks
DE60324703D1 (de) Barbitursäure derivaten.
FI20035067L (fi) Parveke tai vastaava
MA28698B1 (fr) Dicetopiperazines substituees utilisees comme antagonistes des oxytocines
EP1829864A4 (en) ISOCHINOLINE DERIVATIVES AS CALPAININHIBITORS
EP2123291A4 (en) MEANS OF PROMOTING IGA PRODUCTION
EP2076611A4 (en) MN / CA9 SPLICE VARIANTS
EP1891003A4 (en) FLUORALKYLAMINE DERIVATIVES AS CATHEPSIN INHIBITORS
NO20055153D0 (no) Fremgangsmate for fremstilling av maursyreformiater
FR2885962B1 (fr) "tube de pompe"